Clinical trials
Cerebral Hemorrhage trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 2 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 4 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The George Institute | 9 |
| Novo Nordisk A/S | 3 |
| Neuroscience Trials Australia | 2 |
| C. R. Bard | 1 |
| Gold Coast Hospital and Health Service | 1 |
| Johns Hopkins University | 1 |
| Melbourne Health | 1 |
| Region Skane | 1 |
| University of Melbourne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebral Hemorrhage | 20 |
| Stroke | 12 |
| Hypertension | 4 |
| Ischemic Stroke | 4 |
| Cerebrovascular Disorders | 3 |
| Nervous System Diseases | 3 |
| Brain Diseases | 2 |
| Cardiovascular Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Cerebral Small Vessel Diseases | 2 |
Trials
Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.